168 related articles for article (PubMed ID: 20019695)
41. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.
Kerb R; Hoffmeyer S; Brinkmann U
Pharmacogenomics; 2001 Feb; 2(1):51-64. PubMed ID: 11258197
[TBL] [Abstract][Full Text] [Related]
42. Exploring the possible interaction between anti-epilepsy drugs and multidrug efflux pumps; in vitro observations.
Rivers F; O'Brien TJ; Callaghan R
Eur J Pharmacol; 2008 Nov; 598(1-3):1-8. PubMed ID: 18835265
[TBL] [Abstract][Full Text] [Related]
43. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
Yoshida S; Sugawara T; Nishio T; Kaneko S
Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
[TBL] [Abstract][Full Text] [Related]
44. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
45. The pharmacogenomics of epilepsy.
Franco V; Perucca E
Expert Rev Neurother; 2015 Oct; 15(10):1161-70. PubMed ID: 26327193
[TBL] [Abstract][Full Text] [Related]
46. Emerging trends in human ABC transporters.
Ishikawa T
Pharm Res; 2009 Feb; 26(2):445-8. PubMed ID: 19107578
[No Abstract] [Full Text] [Related]
47. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
[TBL] [Abstract][Full Text] [Related]
48. Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
Piana C; Antunes Nde J; Della Pasqua O
Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):341-58. PubMed ID: 24460510
[TBL] [Abstract][Full Text] [Related]
49. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
[TBL] [Abstract][Full Text] [Related]
50. Response to antiepileptic drug therapy: winners and losers.
Brodie MJ
Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468
[TBL] [Abstract][Full Text] [Related]
51. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
[TBL] [Abstract][Full Text] [Related]
52. Pharmacogenomics and epilepsy: the road ahead.
Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
[TBL] [Abstract][Full Text] [Related]
53. Rare protein sequence variation in SV2A gene does not affect response to levetiracetam.
Dibbens LM; Hodgson BL; Helbig KL; Oliver KL; Mulley JC; Berkovic SF; Scheffer IE
Epilepsy Res; 2012 Sep; 101(3):277-9. PubMed ID: 22551666
[TBL] [Abstract][Full Text] [Related]
54. Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy.
Ferraro TN; Dlugos DJ; Buono RJ
Pharmacogenomics; 2006 Jan; 7(1):89-103. PubMed ID: 16354127
[TBL] [Abstract][Full Text] [Related]
55. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
Cascorbi I; Haenisch S
Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
[TBL] [Abstract][Full Text] [Related]
56. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
[TBL] [Abstract][Full Text] [Related]
57. RLIP76, a non-ABC transporter, and drug resistance in epilepsy.
Awasthi S; Hallene KL; Fazio V; Singhal SS; Cucullo L; Awasthi YC; Dini G; Janigro D
BMC Neurosci; 2005 Sep; 6():61. PubMed ID: 16188027
[TBL] [Abstract][Full Text] [Related]
58. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
Potschka H
Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
[TBL] [Abstract][Full Text] [Related]
59. Pharmacotherapy of epilepsy: new armamentarium, new issues.
Vajda FJ
J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
[TBL] [Abstract][Full Text] [Related]
60. Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy.
Shaheen U; Prasad DK; Sharma V; Suryaprabha T; Ahuja YR; Jyothy A; Munshi A
Epilepsy Res; 2014 Feb; 108(2):251-6. PubMed ID: 24300029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
